SCHEMBL8943048

SCHEMBL8943048

CC(C)(C)c1ccc(C=NO)c(O)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.74
SMN1; SMN2 Q16637 2/20 0.74
ALDH1A1 P00352 3/20 0.53
HPGD P15428 1/20 0.53
ALOX15 P16050 1/20 0.53
HSD17B10 Q99714 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
ALOX12 P18054 1/20 0.46
MEN1 O00255 3/20 0.44
GAA P10253 3/20 0.44
KMT2A Q03164 3/20 0.44
PKM P14618 2/20 0.44
KDM4E B2RXH2 1/20 0.44
RECQL P46063 1/20 0.44
HTT P42858 1/20 0.42
FGF23 Q9GZV9 1/20 0.41
LMNA P02545 1/20 0.39
TYR P14679 1/20 0.39
AIMP2 Q13155 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8943045 1.00 MAPT (0.74) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL11521420 0.85 MAPT (1.00) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL11521418 0.85 MAPT (1.00) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL16472974 0.85 MAPT (1.00) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL12724869 0.80 MAPT (0.62) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL31251637 0.80 MAPT (0.62) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL20148142 0.80 MAPT (0.62) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL9782953 0.79 ALDH1A1 (0.59) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL15828703 0.78 MAPT (0.69) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL1527058 0.77 ALDH1A1 (0.57) MAPTSMN1; SMN2ALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0584988-B1 Process for the preparation of salicylaldoxine derivatives ZENECA LTD (GB) 1996-10-23 EP disclosed
US-5502254-A Method for the preparation of 2-hydroxyarylaldoximes ZENECA LIMITED (GB) 1996-03-26 US disclosed
US-5399761-A Method for the preparation of 2-hydroxyarylaldoximes ZENECA LIMITED (GB) 1995-03-21 US disclosed
EP-0584988-A1 Process for the preparation of salicylaldoxine derivatives ZENECA LIMITED (GB) 1994-03-02 EP disclosed